发明公开
EP1524269A1 Use of 8-Prenylnaringenin for hormone replacement therapy
审中-公开
Anwendung von 8-PrenylnaringeninfürHormonersatz-Therapie
- 专利标题： Use of 8-Prenylnaringenin for hormone replacement therapy
- 专利标题（中）： Anwendung von 8-PrenylnaringeninfürHormonersatz-Therapie
-
申请号： EP03090335.5申请日： 2003-10-07
-
公开(公告)号： EP1524269A1公开(公告)日： 2005-04-20
- 发明人: Hümpel, Michael , Schleuning, Wolf-Dieter , Schaefer, Olaf , Isaksson, Päivi , Bohlmann, Rolf
- 申请人： Schering Aktiengesellschaft
- 申请人地址： Müllerstrasse 178 13353 Berlin DE
- 专利权人： Schering Aktiengesellschaft
- 当前专利权人： Schering Aktiengesellschaft
- 当前专利权人地址： Müllerstrasse 178 13353 Berlin DE
- 主分类号： C07D311/32
- IPC分类号： C07D311/32 ; A61K31/35 ; A61P5/00
摘要：
The invention provides a production method for the phytoestrogen 8-Prenylnaringenin, the preparation produced by this method and the use of 8-Prenylnaringenin for the production of a medicament for the prevention and treatment of hormone-dependent osteoporosis and of peri- and postmenopausal symptoms in women.
信息查询
